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Iron acquisition by the gram-negative pathogens Bordetella bronchiseptica and Bordetella pertussis is thought
to occur by hydroxamate siderophore-mediated transport as well as an apparently siderophore-independent
process by which host transferrins bind to bacterial surface receptors. We constructed B. bronchiseptica
mutants deficient in siderophore activity by insertional mutagenesis with miniTn5/LacZl. The mutants could be
placed into four distinct complementation groups, as determined from cross-feeding assays which demon-
strated restored siderophore synthesis. Mutants deficient in siderophore activity were BRM1, BRM6, and
BRM9, exhibiting approximately 36 to 41% of wild-type siderophore levels, and BRM3 and BRM8, which
appeared to produce very little or no detectable siderophore. Mutant BRM4 was found to be a leucine
auxotroph, while mutants BRM2 and BRM7 could synthesize siderophore only in low-iron medium which was
supplemented with various amino acids. Evaluation of all transcriptional fusions revealed an apparent lack of
iron-regulated lacZ expression. Genomic regions flanking the transposable element in the siderophore mutants
were homologous with B. pertussis chromosomal DNA, while bioassays suggested siderophore cross-feeding
between B. pertussis and B. bronchiseptica. These results indicate probable similarity between the siderophore
biosynthetic and transport systems of the two species.
Complex high-affinity iron transport systems are ex-
pressed by microorganisms in response to suboptimal avail-
ability of this nutrient. The prototypic transport system
involves excretion of low-molecular-weight siderophores for
mobilization of iron to the intracellular compartment (30).
Recent studies have described a direct contact uptake mech-
anism in species of Neisseria (24, 38, 43) and Haemophilus
(28, 37) which appears to rely solely on the physical inter-
action of bacterial surface receptors and host iron-binding
proteins such as transferrin or lactoferrin.
Little is known about iron acquisition in members of the
genus Bordetella, which consists of gram-negative respira-
tory pathogens of a variety of animal species (6, 18, 31).
Bordetella pertussis, the etiologic agent of human whooping
cough, and Bordetella bronchiseptica, which primarily in-
fects nonhuman mammals, exhibit a strong affinity for sev-
eral transferrins (25, 33, 34). The assimilation of iron from
cell-bound transferrin by B. pertussis suggested the exist-
ence of a direct-contact iron-sequestering system similar to
that used by the Neisseria and Haemophilus species (33).
Demonstration that B. pertussis grew well when separated
from iron-loaded transferrin by a dialysis membrane (19)
suggested siderophore excretion. The assay of Schwyn and
Neilands (39) was used to detect siderophore activity in
iron-restricted B. pertussis culture supernatants which also
yielded positive results with the Csaky assay for hydroxamic
acids (11), suggesting that the chelator may be of the
hydroxamate siderophore class (19). Iron-stressed B. bron-
chiseptica and Bordetella parapertussis also produce sidero-
phore activity with a putative hydroxamate structure (19).
Bordetella species are usually considered obligate patho-
gens restricted to host respiratory epithelia, yet a report
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describing the ability of B. bronchiseptica to grow in lake
water (32) suggests more diverse ecological niches for this
organism. In addition, B. bronchiseptica has been reported
to cause bacteremia in immunocompromised humans (5, 22).
Such environmental versatility would require adaptation to a
considerably wide variety of physical and nutritional condi-
tions. The source of iron, existing as insoluble oxyhydrox-
ides in external environments or coordinated by animal host
proteins, may differentially influence the expression of si-
derophore genes and those required for the putative direct-
contact iron retrieval mechanism.
As an initial step in our study of iron transport in Borde-
tella species, we used a transposon reporter element to
generate transcriptional fusions in B. bronchiseptica. In this
report, we describe mutants defective in siderophore pro-
duction on low-iron medium and demonstrate potential
relatedness of the siderophore systems of B. bronchiseptica
and B. pertussis by genetic homologies and bioassays.
MATERIALS AND METHODS
Bacterial strains and growth conditions. B. bronchiseptica
B013, derived from swine isolate strain B (15), was from
Robert Goodnow through Charlotte Parker and was the
source of the nalidixic acid-resistant strain B013N. Virulent-
phase B. pertussis UT25 has been described elsewhere (16).
Escherichia coli S17-1(Xpir) (thi thr leu tonA lacY supE
recA::RP4-Tc::Mu-Km::Tn7 X pirR6K) (27, 40) was ob-
tained from Kenneth Timmis via the laboratory of Mark
McIntosh and was used as the donor in mating experiments.
E. coli DH5a [F- o80dlacZAM15 A(lacZYA-argF)U169
endL41 recAl hsdRl7(rK- mK+) deoR thi-1 supE44 X-
gyrA96 rel4l] (Bethesda Research Laboratories, Gaithers-
burg, Md.) was used as a host for routine plasmid construc-
tion. E. coli LG1315 (ara entA lac mtl proC rpsL supE thi
tonA trpE xyl [pColV-K30]) (45) and LG1522 (ara fepA lac
leu mtlproC rpsL supE thi tonA trpE xyl [pColV-K30 iucJ)
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(10) were used for siderophore bioassays. B. bronchiseptica
and B. pertussis were cultured on blood agar or Bordet-
Gengou plates (6, 16) unless otherwise stated; E. coli was
grown on Luria-Bertani (LB) or M9 agar (26). High-iron
culture conditions for B. bronchiseptica were achieved by
use of LB broth or modified Stainer-Scholte (SS) defined
minimal medium containing 36 ,uM iron (36, 41). Transcon-
jugants were cultured in the presence of antibiotics at the
following concentrations: nalidixic acid, 35 ,ug/ml; and kana-
mycin, 30 pg/ml. Propagation of E. coli strains containing
plasmids was in the presence of appropriate antibiotics:
ampicillin at 100 ,ug/ml and kanamycin at 70 pg/ml.
All glassware used for low-iron cultures was treated with
1 M sulfuric acid to decrease residual iron contamination. SS
basal medium was deferrated by passage through a column
packed with ChelexlOO (Bio-Rad, Richmond, Calif.). The SS
vitamin supplement lacked iron and was also deferrated by
using ChelexlOO. MgCl2 and CaCl2 in distilled H20 were
added to the medium (final concentrations of 0.5 and 0.2
mM, respectively) to replace the magnesium and calcium
ions removed during deferration. Amino acid supplements
were prepared in distilled water, deferrated by using
ChelexlOO, and filter sterilized. Liquid medium was inocu-
lated with cells grown previously in high-iron broth and
washed three times in deferrated SS basal medium. Growth
was at 370C on an orbital shaker and was measured as optical
density (OD) with a spectrophotometer or a Klett-Summer-
son colorimeter equipped with a no. 54 filter (Klett Mfg. Co.,
Long Island City, N.Y.).
High-iron cyclodextrin solid medium (CSM) was prepared
as described previously (21), using Molecusol MB cyclodex-
trin from Pharmatec Inc. (Alachua, Fla.). Low-iron CSM
was produced by treatment of molten CSM medium with
ChelexlOO prior to autoclaving and was supplemented with a
mixture of 20 deferrated L-amino acids.
Chrome azurol S (CAS) agar for the evaluation of B.
bronchiseptica siderophore production was a modification of
the formulation of Schwyn and Neilands (39). Briefly, a
150-ml volume of sterile CAS-iron dye reagent was added to
850 ml of autoclaved SS (pH 7.0) containing 1.5% agar and
the usual SS vitamin supplement to produce the blue me-
dium. B. bronchiseptica siderophore excretion was evident
on CAS agar after incubation for 48 h at 37°C.
Bioassays. For siderophore bioassays, the B. pertussis
indicator strain was applied as a lawn to the surface of
low-iron CSM. Supernatants from test strains of B. bronchi-
septica grown in low-iron SS without antibiotics and con-
taining deferrated L-amino acids were filter sterilized, and
200-,ul volumes were placed in wells cut into the agar. To
correct for differences in the final ODs of the cultures, the
supernatants were diluted accordingly with deferrated SS.
Other bioassays on low-iron M9 agar (supplemented with 20
deferrated L-amino acids) involved patching test organisms
onto the E. coli LG1522 indicator lawn prior to incubation.
Bioassays in low-iron liquid medium were performed by
adding 3-ml volumes of filter-sterilized culture supernatants
(derived from late-logarithmic-stage bacteria cultured in
low-iron SS) to 7 ml of low-iron SS. B. bronchiseptica strains
were inoculated at low density (20 Klett units) and moni-
tored for growth. Controls included no additions to 10 ml of
low-iron SS and addition of FeCl3 (to 36 ,uM) to 10 ml of
low-iron SS.
Cross-feeding assays on CAS agar were performed by
cross-streaking B. bronchiseptica strains on the agar or by
supplying (on filter disks) each streaked strain with low-iron
culture supernatants concentrated 10-fold by lyophilization.
Mutagenesis. Transcriptional fusions were constructed by
using plasmid pUT containing miniTnSllacZl (gift of Ken-
neth Timmis) (12, 20). B. bronchiseptica B013N was grown
overnight on LB agar containing 35 pg of nalidixic acid per
ml, while the donor strain, E. coli S17-1(Xpir) carrying
pUT::miniTnSllacZl, was grown overnight on LB agar con-
taining kanamycin. Bacteria were harvested from the plates
and washed in 10 mM NaCl. The cell density was adjusted to
an OD at 600 nm (OD600) of 1.0 in LB broth, and the cells
were mixed in a ratio of 1:1. After 0.5 ml of the cell mixture
was spread onto LB agar containing 20 mM MgSO4 (44), the
cells were dried onto the surface of the medium and incu-
bated for 6 h at 370C. The cells were harvested and plated
onto LB agar containing kanamycin and nalidixic acid and
also spread with 30 to 50 pl of a colicin B-enriched bacterial
lysate (approximately 5 mg of total protein per ml) to
additionally discourage growth of E. coli donors (9).
Transconjugants were patched onto CAS agar for assess-
ment of siderophore activity.
Determination of siderophore in culture supernatants. Mu-
tants lacking siderophore haloes on CAS agar were grown in
high-iron and low-iron SS broth, with amino acid supple-
ments if appropriate. Supernatants were harvested at inter-
vals and tested for siderophore activity by the CAS assay
(39) in which the reactions were allowed to proceed for 4 h
prior to measurement of OD630. The assay of Arnow (3) was
used to detect phenolate-based siderophore compounds,
while the determination of hydroxamates was accomplished
by the Csaky protocol, using hydroxylamine hydrochloride
as a standard (11). Reported values for all siderophore
detection assays were calculated with the measurements
from 4 to 14 separate experiments.
Spectral analysis of culture supernatants of iron-starved
cells was performed by using a Beckman DU-65 spectropho-
tometer (Beckman Instruments, Inc., Fullerton, Calif.) at
wavelengths ranging continuously from 200 to 700 nm.
Filter-sterilized supernatants were analyzed both without
and with FeCl3 added to a final concentration of 74 ,uM.
DNA methods. Plasmid DNA was isolated by routine
procedures (35), while genomic DNA was recovered from B.
bronchiseptica and B. pernussis by the method described by
Brown and Parker (8). Restriction endonuclease digestions
and ligations were performed with products from Promega
(Madison, Wis.) or United States Biochemical (Cleveland,
Ohio) in accordance with the manufacturers' instructions.
Southern hybridization analysis was performed as de-
scribed previously (34), using Biotrace RP nylon membranes
(Gelman Sciences, Ann Arbor, Mich.). Immobilized genomic
DNA was examined for the presence of transposon sequences
by using a 32P-labeled probe obtained from pUT::miniTnS/
lacZl as a ca. 5.0-kb BamHI-EcoRI fragment which contains
virtually the entire transposable element. Probes were labeled
by random priming with the Promega Prime-a-Gene product.
For detection of delivery plasmid-specific sequences, a ca.
2.0-kb BamHI fragment from pUT::miniTnS/lacZl was used
as the source of probe DNA. Other probes were isolated as
described in the text. Hybridization was performed at 68°C in
6x SSPE (0.9 M NaCl, 0.06 M NaH2PO4. H20, 6 mM
EDTA). Stringent conditions were maintained by washing the
blots at 68°C in 0.1x SSC-0.1% sodium dodecyl sulfate (lx
SSC is 0.15 M NaCl plus 0.015 M sodium citrate).
Transposon markers were cloned from B. bronchiseptica
mutants by using conventional methods (35). Genomic DNA
was digested with EcoRI or Sal, and the fragments were
size selected (on the basis of Southern hybridization data)
and ligated into the appropriately restricted vector pGEM3Z
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FIG. 1. Southern hybridization analysis of B. bronchiseptica
mutants. Chromosomal DNA samples from mutants and the paren-
tal strain were digested with EcoRI, electrophoresed on a 0.5%
agarose gel, and transferred to a nylon membrane prior to probing
with a ca. 5-kb 32P-labeled fragment specific for miniTnl5/lacZl.
Lanes: P, ca. 5-kb fragment from miniTnS/lacZ1 from which the
probe was derived; 1 to 9, chromosomal DNA from mutants BRM1
to BRM9, respectively; B, genomic DNA from parental strain
B013N. Size markers are indicated at the left.
(Promega). E. coli DH5a transformants were selected on
ampicillin- and kanamycin-containing LB agar.
13-Galactosidase measurements. 1-Galactosidase activity of
the mutants was determined by the method of Miller (26).
The assay was performed several times (each in triplicate) on
cells grown in high-iron and low-iron SS media. Qualitative
evaluation of P-galactosidase activity was accomplished by
growth on high- and low-iron CSM agar containing 0.04 mg
of 5-bromo-4-chloro-3-indolyl-13-D-galactoside (X-Gal) per
ml.
RESULTS
Isolation of B. bronchiseptica insertion mutants. Approxi-
mately 9,000 nalidixic acid- and kanamycin-resistant B.
bronchiseptica transconjugants were patched onto CAS agar
to detect organisms deficient in siderophore excretion. Ran-
domly chosen transconjugants as well as the apparent si-
derophore mutants carried no pUT::miniTnSllacZI plasmid
DNA. Southern hybridization experiments confirmed that
the element alone and not the entire plasmid had integrated
into the chromosomes of putative siderophore mutants (data
not shown).
Chromosomal DNA isolated from siderophore-deficient
mutants (designated BRM1 to BRM9) was digested with
EcoRI (which does not cut within the miniTnSllacZl ele-
ment) and analyzed by Southern hybridization using a trans-
poson-specific probe (Fig. 1). Each of the nine mutants
demonstrated a single hybridizing DNA fragment. Digestion
of genomic DNA with both EcoRI and BamHI followed by
hybridization with the same probe distinguished BRM1 from
BRM9, whereas analysis with these and other restriction
enzymes indicated that BRM5 and BRM8 were siblings (data
not shown). Therefore, eight independent insertion events
defined the collection of mutants. Cryptic plasmid DNA
isolated from the mutants failed to hybridize with the
miniTn5/lacZl-specific probe (data not shown).
Analysis of siderophore deficiency. The mutants were
tested several additional times on the blue CAS agar with
consistent results (Fig. 2). The parent strain B013N exhib-
ited a distinct wide yellow halo indicative of siderophore
FIG. 2. Growth and siderophore production on CAS agar. Sus-
pensions of washed bacteria were spotted onto CAS agar and
incubated for 48 h at 370C. The letter P is located near the growth
and siderophore halo of parental strain B013N; the numbers 1 to 9
identify mutants BRM1 to BRM9, respectively.
excretion, while the mutants grown on the same agar dem-
onstrated no apparent siderophore activity.
Further assessment of the mutants confirmed the extent of
their siderophore deficits (Table 1). After growth of parental
strain B013N and the mutants in low-iron SS, cell-free
culture supernatants were analyzed by a quantitative CAS
siderophore assay. Supernatant from B013N demonstrated a
large reduction in OD630 as the result of strong iron-chelating
activity. B013N grown in high-iron SS did not produce
CAS-reactive material. The mutants showed only a small
TABLE 1. Production of siderophore activity by B.
bronchiseptica mutants grown in deferrated minimal SS medium
Strain CAS activitya (mM AbsorptionStrain
~ (OD630 ±SD) stndrd spectrac
B013N 0.14 ± 0.04 (100) 0.32 ± 0.04 +
BRM1 0.43 ± 0.03 (14) 0 -
BRM2 0.46 ± 0.03 (3) 0 -
BRM3 0.48 ± 0.02 (0) 0 -
BRM4d 0.47 ± 0.05 (1) 0 -
BRM6 0.44 ± 0.02 (10) 0.05 ± 0.02 -
BRM7 0.42 + 0.06 (17) 0 -
BRM8 0.46 ± 0.02 (4) 0 -
BRM9 0.42 + 0.03 (17) 0 -
None (uninoculated 0.47 ± 0.01 (0) 0 -
medium)
I Cell-free culture supernatants of bacteria grown in low-iron medium to
late logarithmic stage were tested by using the CAS assay as detailed in
Materials and Methods. A low OD630 relative to that of uninoculated medium
indicates siderophore activity; values in parentheses represent the percent of
the parental level of activity as calculated from the mean. Strain B013N
cultured under iron-replete conditions yielded an OD630 of 0.63.
b Cell-free supernatants of iron-deficient bacteria were subjected to the
Csaky assay as described in Materials and Methods. An increase in OD500
relative to uninoculated medium and as compared with a standard indicates
the presence of hydroxamic acids; the value given is the concentration of
hydroxylamine hydrochloride equivalent and is the average of at least three
independent experiments. Strain B013N cultured under iron-replete condi-
tions routinely gave a value of 0.
c Cell-free supernatants of bacteria were analyzed by spectroscopy as
described in Materials and Methods. +, spectra characteristic of siderophores
(for B. bronchiseptica BO13N, a kma. shift from 305 to 425 nm upon ferration);
-, lack of absorbance at wavelengths in the range of 290 to 700 nm.
Displayed poor growth in SS.
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FIG. 3. Phenotypic cross-complementation on CAS agar. B.
bronchiseptica mutants were cross-streaked on CAS agar and
incubated for 48 h at 37°C. Results of the analysis of BRM6 (vertical
primary streak) with BRM1, BRM2, BRM3, and BRM8 are shown.
reduction in OD630, signifying a lack of siderophore activity
in the culture supernatants. These mutants were analyzed
throughout the entire growth phase with similar results.
Culture supernatant from iron-starved B013N grown to
late exponential phase and tested for the presence of hydrox-
amic acids yielded the equivalent of 0.32mM hydroxylamine
hydrochloride standard. Hydroxamic acids were absent in
the supernatants of all similarly cultured mutants with the
exception of BRM6, which produced trace levels of hydrox-
ylamine hydrochloride equivalent (0.05 mM). B013N cul-
tured in high-iron SS did not produce detectable hydroxam-
ates.
As siderophores and their ferric chelates display charac-
teristic absorption spectra (30), supernatants of iron-stressed
cells were analyzed spectrophotometrically. Supernatant
from B013N or wild-type B013 demonstrated maximal ab-
sorbance at 305 nm which shifted to 425 nm when iron was
added. Similar tests performed on iron-free or ferrated
supernatants from the iron-starved mutants showed no mea-
surable absorption in the range of 290 to 700 nm.
CAS cross-feeding analysis. Cross-feeding assays were
performed to determine whether any mutant produced and
excreted an intermediate of siderophore biosynthesis which
could be used by another mutant to alleviate its presumed
block in the biosynthetic pathway. In four independent
experiments, distinct zones of siderophore production were
observed at the junctions where certain mutants were cross-
streaked onto CAS agar (Fig. 3). Strong siderophore activity
was produced at the junctions where BRM3 and BRM8 were
cross-streaked with BRM6. Slight activity was observed at
the area where BRM2 and BRM6 intersected, while the
combination of BRM1 and BRM6 demonstrated no sidero-
phore halo. Compilation of the data revealed that the eight
mutants could be divided into four phenotypic complemen-
tation groups (Table 2). To determine which mutants sup-
plied the siderophore-stimulating compounds and which
mutants were fed by such compounds, concentrated cell-free
supernatants were used to test each mutant. Group I mutants
were fed by no others but supplied stimulating factors to
members of groups II and III. Group II mutants were fed by
group I but were unable to supply any other mutant. Group
III mutants were fed by group I organisms and stimulated the
group IV mutant, BRM4. Supernatant cross-feeding experi-
ments between groups II and III produced variable results
which could not be unequivocally determined. BRM4 was
fed weakly by group III organisms and appeared incapable of
feeding any other mutant.
Effect of amino acids on growth and siderophore produc-
tion. The mutants displayed variable rates of growth in
low-iron SS liquid medium (Table 3). Experiments consis-
tently showed the mean generation times of BRM1, BRM6,
and BRM9 to be similar to that of the parent strain. BRM3
and BRM8 displayed somewhat diminished growth capacity
which was greater than that of BRM2 and BRM7. Both
mutant and wild-type cells demonstrated increased growth in
high-iron SS, but the rates of BRM3, BRM8, BRM2, and
BRM7 were still below that of the wild-type (data not
shown). BRM4 failed to grow in high-iron or low-iron SS
unless a large inoculum was used, in which case the growth
was still rather poor (data not shown). Inclusion of 20
deferrated L-amino acids in the medium (Table 3) dramati-
cally enhanced the growth of BRM4, suggesting amino acid
auxotrophy; CAS and Csaky (not shown) assays detected
parental levels of siderophore activity and hydroxamate,
respectively, in the BRM4 supernatant. Amino acid supple-
mentation slightly improved the growth of BRM2 and BRM7
and also restored siderophore production. Similar amino
acid additions, although not enhancing the growth of BRM1,
TABLE 2. Phenotypic cross-complementation of B. bronchiseptica siderophore mutants
Complementation M Siderophore produced when streaked Produces siderophore when Supplies siderophore stimulus to
group utant against BRM mutantsa fed by BRM mutantsb BRM mutant(s)b
I BRM1 2, 3,7,8 None 2, 3,7,8
BRM6 2,3,7,8 None 2, 3, 7,8
BRM9 2, 3, 7,8 None 2, 3,7,8
II BRM2 1,3,6,8,9 1,6,9c None
BRM7 1,3,6,8,9 1,6,9c None
III BRM3 1, 2, 4,6,7,9 1,6, 9 4
BRM8 1, 2, 4,6,7,9 1,6, 9 4
IV BRM4 3, 8e 3, 8e None
Mutants were cross-streaked on CAS agar and evaluated for siderophore synthesis on the basis of results such as those depicted in Fig. 3; results were
consistent in four independent experiments.
b Mutants were streaked onto CAS agar and supplied with concentrated cell-free supernatants derived from BRM mutants cultured in low-iron SS minimal
medium. Siderophore production was scored by the presence or absence of characteristic yellow haloes surrounding filter disks containing the supernatants.
Results are from three experiments, each performed in duplicate.
c Results with BRM3 and BRM8 supernatants were too variable to be conclusive.
d Results with BRM2 and BRM7 supernatants were too variable to be conclusive.
e Weak siderophore activities were observed with both BRM3 and BRM8 and their supernatants.
VOL. 175, 1993
1148 ARMSTRONG AND CLEMENTS
TABLE 3. Mutant growth and effect of medium composition on siderophore activity
CAS activity" (OD630 ± SD) in deferrated minimal SS plus:
Complementation Strain (generation
group time [h])" No additions' All amino acids' Leucne All amino acids
except leucine
Wild type B013N (3.8) 0.14 + 0.04 (100) 0.14 ± 0.03 (100) 0.15 ± 0.04 (100) 0.11 ± 0.04 (100)
I BRM1 (4.0) 0.43 ± 0.03 (14) 0.33 + 0.05 (41) _
BRM6 (4.2) 0.44 ± 0.02 (10) 0.35 ± 0.06 (36)
BRM9 (4.0) 0.42 + 0.03 (17) 0.34 ± 0.05 (39)
II BRM2 (9.5) 0.46 ± 0.03 (3) 0.17 ± 0.03 (91) 0.15 ± 0.06 (100) 0.14 ± 0.06 (91)
BRM7 (11.3) 0.42 ± 0.06 (17) 0.16 ± 0.02 (92) 0.18 ± 0.02 (90) 0.15 + 0.05 (88)
III BRM3 (5.5) 0.48 + 0.02 (0) 0.46 ± 0.02 (3)
BRM8 (6.4) 0.46 ± 0.02 (4) 0.45 + 0.03 (5)
IV BRM4 (no growth) 0.47 + O.OS'f (1) 0.18 + 0.02 (87) 0.18 ± 0.04 (90) 0.52 + 0.05f (0)
a Mean generation time during growth in the usual low-iron minimal SS with no amino acid supplements.
"Culture supernatants of bacteria grown in low-iron medium were tested by using the CAS assay as detailed in Materials and Methods. A low OD630 relative
to that of uninoculated medium indicates siderophore activity; values in parentheses represent the percent of the parental level of activity as calculated from the
mean.
c Values taken from Table 1 for comparison.
d Each of 20 deferrated L-amino acids was added to a final concentration of 50 pg/ml. For other experiments, individual amino acids were used at the same
concentration.
e, not determined.
f Little or no growth from small inocula was observed.
BRM6, and BRM9, did result in increased siderophore
production to approximately 36 to 41% of the wild-type
level. BRM3 and BRM8 were unaffected by addition of
amino acids to the medium; their growth remained un-
changed, and they still failed to produce significant sidero-
phore activity. Neither the mutants nor the wild-type strain,
regardless of low-iron medium composition, demonstrated
phenolate types of siderophore compounds as determined by
the assay of Arnow (3) (data not shown).
Testing of specific amino acids revealed that BRM4
growth and subsequent siderophore production were depen-
dent upon an exogenous supply of leucine only (Table 3).
Although BRM2 and BRM7 could grow in the absence of
leucine, this amino acid enhanced their growth and elicited
wild-type levels of siderophore activity. A mixture of amino
acids lacking leucine also had the capacity to stimulate
siderophore production in these mutants. In other experi-
ments (data not shown), a number of amino acids, alone or in
combination, potentiated siderophore production in BRM2
and BRM7. These included tryptophan, tyrosine, serine,
asparagine, aspartic acid, glutamine, methionine, phenylala-
nine, proline, and the combinations isoleucine-valine and
glycine-histidine-lysine.
13-Galactosidase expression. Qualitative examination of all
BRM mutants on X-Gal-containing low- and high-iron CSM
agar failed to reveal any iron-regulated reporter gene activ-
ity, as they appeared to process similar amounts of chromo-
genic substrate. Quantitative evaluation of the siderophore
mutants in groups I and III demonstrated generally equiva-
lent or lower P-galactosidase levels upon culture in low-iron
conditions compared with those obtained after growth in
high-iron medium. For example, mutants BRM3 and BRM8
demonstrated the following ,-galactosidase levels (mean
values, in Miller units) in high- and low-iron media, respec-
tively: BRM3, 239 and 137; and BRM8, 1,106 and 857.
Analysis of group II and group IV mutants also revealed a
lack of iron-regulated lacZ expression (data not shown).
Cloning of genomic DNA containing miniTn5/lacZI inser-
tions. The chromosomal regions containing miniTnSllacZ1
insertions of the siderophore-deficient mutants were cloned
for use as probes and to allow comparison of the flanking
DNA regions of members in each phenotypic complementa-
tion group (Fig. 4). Restriction endonuclease maps, along
with results of Southern hybridizations using probes gener-
ated from the clones (data not shown), revealed the inser-
tions of group I mutants to be on the same ca. 15-kb SalI
chromosomal fragment. Analysis of a Sall fragment isolated
from group III mutants BRM3 and BRM5 (identical to
BRM8) showed that the insertions were 200 to 300 bp from
one another.
Comparative analyses with B. pertussis. Southern hybrid-
Group I
B Sm --
pBRM6 S E P | PEP E
pBRM9
pBRM1
B Smn
EPLL
p
Y E
pBRM5 S S
Goup III
pBRMV3 I
L_ E 2kb
FIG. 4. Partial restriction maps of cloned genomic regions from
siderophore-deficient mutants. The name of each plasmid which
contains the insert identifies the mutant from which the cloned DNA
originated. Triangles indicate the positions of miniTnS/lacZl; ar-
rows denote direction of transcription of the trp'-'lacZ reporter
gene. Maps were constructed on the basis of restriction enzyme
digestions. Group-specific maps were aligned by using information
derived from restriction enzyme maps and Southern hybridizations.
Striped boxes show fragments used as probes for the Southern
hybridizations shown in Fig. 5. Abbreviations: B, BamHI; E,
EcoRI; P. PstI; S, SalI; Sm, SmaI.
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FIG. 5. Southern hybridization analysis of chromosomal DNA
from B. bronchiseptica B013 (lanes 1) and B. pertussis UT25 (lanes
2). The DNA was digested with EcoRI and processed as described
for Fig. 1, using probes derived from pBRM1 and pBRM3, as
indicated. Size markers (in kilobases) are indicated at the left.
izations at high stringency and using probes (shown in Fig. 4)
from genomic regions flanking the insertions in mutants
BRM1 and BRM3 showed cross-hybridization with B. per-
tussis UT25 chromosomal DNA (Fig. 5). Similarly sized 5.2-
to 5.3-kb EcoRI fragments from B. bronchiseptica B013 and
B. pertussis UT25 hybridized with the BRM1 probe. The
BRM3 probe, a ca. 1.0-kb fragment derived from pBRM3,
hybridized to a ca. 17-kb EcoRI fragment from B. bronchi-
septica B013 and a fragment greater than 23 kb from B.
pertussis UT25. The analogous 1.0-kb probe from pBRM5
showed the same hybridization patterns with B013 and UT25
chromosomal DNA (data not shown).
If the siderophore systems of B. bronchiseptica and B.
pertussis were identical or very similar, it might be expected
that their siderophores or excreted siderophore intermedi-
ates would cross-feed each other in low-iron environments.
Supernatants of B013N and BRM mutants (grown in low-
iron SS with amino acid supplements to circumvent the
nutritional deficits of group II and group IV mutants) were
tested for the ability to relieve the initial iron stress of B.
pertussis UT25 in bioassays on low-iron CSM agar. Super-
natants from siderophore-producing B. bronchiseptica
strains were able to maximally enhance iron-restricted
growth of B. pertussis UT25 (Table 4). Group III mutant
supernatants were less capable of doing so, displaying weak
or no haloes of UT25 growth stimulation. There was no halo
formation around wells containing uninoculated medium.
The equivalent experiments on high-iron CSM produced an
even lawn of UT25 growth on the entire agar surface, with
no haloes surrounding the supernatant wells (not shown).
Experiments using B. bronchiseptica strains patched onto
the B. pertussis lawn yielded similar results: as the sidero-
phore-producing strains grew, they excreted compounds
which enhanced the growth of B. pertussis; there was no
halo formation around B. pertussis UT25 itself spotted onto
the agar.
To evaluate the reciprocal cross-feeding, B013N was
tested for the ability to use B. pertussis UT25 CAS-positive
low-iron supernatant to relieve iron stress. Because the
siderophore-proficient B. bronchiseptica B013N proved dif-
ficult to test on low-iron CSM (it always grew as a lawn, with
no haloes even around an iron source), experiments were
performed by using low-iron liquid cultures supplemented
with filter-sterilized spent culture supernatants containing
putative siderophore material. In liquid medium, cross-
TABLE 4. Stimulation of B. pertussis growth on low-iron agar by
B. bronchiseptica culture supernatantsa
Complementation B. bronchiseptica B. pertussis growth
group supernatant stimulation level
Wild type B013N + + +
I BRM1 + +
BRM6 + +
BRM9 ++
II BRM2 + +
BRM7 + +
III BRM3 -/+
BRM8 -/+
IV BRM4 + +
a B. pertussis UT25 was swabbed onto low-iron CSM agar, and B. bron-
chiseptica filter-sterilized culture supernatants (from late-logarithmic-stage
bacteria cultured in low-iron SS with amino acid supplements) were added to
wells in the agar. Haloes of B. pertussis UT25 growth were measured around
the wells after incubation for 72 h. The following halo measurements represent
mean diameters and exclude the 8 mm contributed by the sample well: + + +,
a dense halo with a diameter range of 17 to 22 mm; + +, a moderately dense
halo with a diameter in the range of 9 to 16 mm; -/+, no stimulation ranging
to a faintly visible halo of 1 to 5 mm. Reported results are from three to four
separate measurements. Uninoculated medium did not stimulate B. pertussis
growth.
feeding would be manifested as enhanced initial growth due
to inhibition of the normally observed low-iron growth lag.
Such experiments consistently showed that B. bronchisep-
tica B013N, inoculated at low density into low-iron SS,
displayed stimulated growth upon addition of CAS-positive
supernatants from B. pernussis UT25 and B013N itself (Fig.
6). Organisms in unsupplemented medium demonstrated the
usual extended lag phase during culture, while those in
high-iron SS grew to the greatest final optical density.
B. bronchiseptica was analyzed to determine whether it
could cross-feed E. coli. Bioassays on low-iron M9 minimal
agar showed that neither B. bronchiseptica B013N nor its
CAS-positive supernatants could relieve the iron stress of
the indicator E. coli strain LG1522 (an aerobactin biosyn-
thetic mutant still able to transport aerobactin). In contrast,
the aerobactin-producing E. coli strain LG1315 stimulated a
large growth halo of LG1522 on the same medium (data not
shown).
-
S
-
CS
U
0.
0._
I;
100
1 0
1 0 20
O No addition
A +Fe
* + UT25 supt.
* + B013N supt.
Time (hours)
FIG. 6. Growth of B. bronchiseptica B013N in low-iron SS.
Strain B013N was inoculated at 20 Klett units into low-iron SS
containing no additions, 36 ILM iron, or low-iron CAS-positive
culture supernatants (supt.) from B. pertussis UT25 or B. bronchi-
septica B013N.
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DISCUSSION
We selected the element miniTnSllacZl for construction
of transcriptional fusions in B. bronchiseptica to facilitate
the study of iron-regulated siderophore gene expression,
which in E. coli is primarily mediated by the Fur repressor
protein and is maximal during iron stress and repressed
under iron-replete conditions (4, 7, 14). In contrast, our
siderophore mutants displayed somewhat similar levels of
P-galactosidase regardless of iron concentration of the cul-
ture medium. E. coli strains carrying plasmids pBRM3 and
pBRM5 (Fig. 4) also failed to demonstrate iron-regulated
lacZ expression (data not shown). One interpretation of
these results is that while siderophore production is iron
regulated, the gene which is mutated is not. Alternatively,
the iron-responsive element or regulatory signal may be
inactivated by the mutation. As the orientation and position
of the insertion with respect to the transcriptional unit are
unknown, sequencing of the flanking DNA regions as well as
transcript analysis may provide insight into the lack of
expected regulation.
The mutants isolated in this study were initially identified
by the absence of a siderophore halo after growth on
SS-based minimal agar incorporating the iron-binding dye
CAS (39). Supernatants of these bacteria cultured in defer-
rated minimal SS also did not react significantly with the
CAS dye. As the color change of the dye corresponds with
loss of the iron, siderophore iron-chelating activity rather
than the siderophore chemical structure itself is detected.
Other criteria such as absorption spectrum analysis and the
Csaky assay confirmed the paucity of hydroxamate com-
pounds in the mutants.
Mutants capable of feeding one another siderophore bio-
synthetic precursors to alleviate pathway defects have been
described for the enterobactin (17, 46) and aerobactin (13)
siderophore systems. CAS agar cross-feeding assays per-
formed in this study clearly showed that siderophore was
produced only when certain strains comprising distinct com-
plementation groups were streaked in contact with one
another. Throughout this study, members of each group
were found to share siderophore production and growth
characteristics, and the mutations of members of each of
groups I and III were found in close proximity on discrete
genomic fragments. To distinguish the factor-producing from
the factor-using strains on CAS agar, filter-sterilized concen-
trated supernatants from iron-starved mutants were used.
That group I siderophore-deficient mutants supplied factors
to groups II and III but could not be fed by any others
suggests that these mutants are blocked in a later step in the
siderophore biosynthetic pathway. In light of the amino acid
supplementation experiments, it is likely that for mutants
BRM2, BRM4, and BRM7, the siderophore-stimulating fac-
tors that they required were amino acids or their biosyn-
thetic intermediates. It is unknown why BRM4 was not
cross-fed by group I mutants. Cross-feeding between groups
II and III was difficult to determine, as the results varied
considerably. These organisms may be blocked at early
steps in siderophore synthesis, as they appear incapable of
feeding the group I siderophore mutants. It is possible that
groups II and III need to cross-feed each other simulta-
neously. Alternatively, the stimulating factor may have a
short half-life and would need to be continually produced by
growing organisms for the cross-feeding effect. Because
group II and group IV mutants did not grow optimally in the
minimal medium, their supernatants may have lacked suffi-
cient concentrations of the putative siderophore intermedi-
ates for adequate feeding of the other mutants.
The B. bronchiseptica mutants displayed various rates of
growth in low-iron SS. This Tris-buffered medium, which
routinely supports the growth of Bordetella spp., contains
salts, phosphate, ascorbate, nicotinamide, glutathione, cys-
tine, glutamate, and proline (36, 41). Members of group II
and group III grew at an intermediate rate in deferrated SS,
while the only group IV member, BRM4, failed to grow from
small inocula in both low-iron and high-iron SS. Our exper-
iments suggest that BRM4 is a leucine auxotroph, and its
inability to produce detectable siderophore may be related to
extremely poor growth in the absence of leucine. Another
consideration is that the siderophore molecular structure
itself may be derived from leucine. It was noted that BRM2
and BRM7, while not obvious auxotrophs, produced sidero-
phore upon the addition of various amino acids which are
synthesized by different biochemical pathways. The muta-
tions of these group II members may affect some central or
regulatory aspect of amino acid metabolism to which bio-
synthesis of the siderophore is secondary. Under low-iron
conditions in minimal SS, the siderophore would not be
produced in these mutants, as other biosynthetic needs must
be met first. This would explain the inability of group II
supernatants to feed group III mutants on CAS agar.
Group I mutants exhibited reduced siderophore output, as
under the best conditions, the maximal level of activity was
only 36 to 41% of that of the parent strain B013N. The leaky
phenotype may be due to defective siderophore excretion or
to polar effects of the insertion on a siderophore biosynthetic
gene or one involved in the positive regulation of biosyn-
thetic genes. The ability of group I mutants to grow as well
as wild-type B013N under low-iron conditions may be due to
a postulated naturally low requirement for iron (19) coupled
with the observed low levels of siderophore production. The
pronounced siderophore deficiency of group III mutants
BRM3 and BRM8 was unaffected by the amino acid compo-
sition of the growth medium, suggesting insertional inactiva-
tion of a genetic locus directly required for siderophore
biosynthesis or one involved in positive regulation of syn-
thesis. As the transposon elements in these mutants were
chromosomally located, it may be presumed that, unlike
ColV plasmid-encoded aerobactin genes (13), the genes
encoding B. bronchiseptica siderophore function probably
do not reside on the cryptic plasmid found in strain B013.
Gorringe et al. first identified in culture supernatants of
iron-starved B. pertussis, B. parapertussis, and B. bronchi-
septica the CAS and Csaky activities characteristic of hy-
droxamate siderophores (19). A subsequent study confirmed
the presence of siderophore activity in B. pertussis superna-
tants and characterized it by spectral analysis (1). The
reported absorbance maximum of ferrated B. pertussis su-
pernatant at 450 nm differed from our 425-nm value for
similarly tested B. bronchiseptica. It is unknown whether
the B. pertussis supernatant material, termed bordetellin by
Agiato and Dyer (1), is identical to that which we have
described for B. bronchiseptica B013. Purification and chem-
ical analysis of the compounds from each organism will
clarify their molecular structures. The B. bronchiseptica
siderophore probably does not resemble the hydroxamate
siderophore aerobactin, as CAS-positive supernatants were
unable to cross-feed an aerobactin-utilizing strain of E. coli.
Our finding that B. pertussis and B. bronchiseptica are
cross-fed by each other in low-iron cultures suggests that
each produces a siderophore which can also be used by the
other species. The occasionally observed faint level of B.
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pertussis low-iron growth enhancement by group III sidero-
phore mutants may be due to their excretion of siderophore
biosynthetic intermediates or other stimulatory metabolites
or of compounds which may condition the medium by
inactivating inhibitors in the agar to which B. pertussis is
sensitive (21). The observation that B. pertussis DNA is
homologous with the DNA regions flanking the insertions in
BRM3 and BRM8 further strengthens the concept of the
same or a similar siderophore system in both species. One
line of evidence which does not appear to support the idea of
an identical siderophore produced by both species involves
iron-regulated outer membrane proteins which might func-
tion in the transport of the ferrisiderophore complex.
Menozzi et al. reported iron-repressed B. pertussis outer
membrane proteins of 70 and 27 kDa, yet the analogous
proteins in B. bronchiseptica were 79.5, 73.5, 32, and 30 kDa
(25). Agiato and Dyer found B. pertussis iron-repressed
outer membrane proteins with molecular sizes of 93, 77, and
63 kDa (1). Considering the high degree of genetic related-
ness between B. pertussis and B. bronchiseptica (23, 29), if
these organisms synthesized identical siderophores, one
might expect more similarly sized putative transport pro-
teins.
In Bordetella spp., the vir genetic locus (bvgAS) coordi-
nates the regulation of virulence-associated genes by a
proposed two-component type of mechanism (2, 42). Borde-
tella iron acquisition genes do not appear to be regulated by
bvgAS, as Gorringe et al. found that avirulent-phase B.
pertussis produced siderophore activity equivalent to that of
virulent strains (19). Redhead et al. found avirulent B.
pertussis capable of binding transferrins as well as virulent-
phase bacteria (34), while Menozzi et al. showed that iron-
repressed outer membrane protein production in B. pertussis
and B. bronchiseptica was unaffected by nicotinic acid-
induced phenotypic modulation (25).
B. pertussis and B. bronchiseptica are thought to utilize
not only a siderophore-mediated iron uptake system but also
a putatively siderophore-independent mechanism involving
the direct binding of transferrin and lactoferrin. The B.
bronchiseptica siderophore mutants obtained in this study
provide an opportunity to ascertain the contribution of each
system to iron acquisition under different in vitro and in vivo
conditions and to determine whether the direct-contact
mechanism is truly independent of siderophore function.
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